NEW YORK, Feb 21 - Zygogen of Atlanta will provide Curis with its
proprietary transgenic zebrafish technology for use in genomics-based drug
discovery, Zygogen said Wednesday.
Zebrafish are similar to knockout mice in that they can serve as model
organisms for finding genome-based drug targets, but they offer the
advantage of being faster to breed and less expensive.
Zygogen, founded in 1999, uses Z-Tag, a technology through which it can
design transgenic zebrafish with organs that are labeled and cell lineages